TITLE

Late Breaking Abstracts for the 31st European Society for Dermatological Research (ESDR) Meeting 2001 Stockholm, Sweden September, 20-22, 2001

PUB. DATE
December 2001
SOURCE
Journal of Investigative Dermatology;Dec2001, Vol. 117 Issue 6, p1677
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents abstracts related to dermatology in Stockholm, Sweden. 'Critical Role of JNK in Mediating the Antagonistic Activity of TNF-alpha Against TGF-beta/Smad Signaling and Collagen Gene Transcription'; 'Effects of Vascular Endothelial Cell Growth Factor (VEGF) Deletion on Skin Biology and Mammary Gland Development and Function'; 'Proteinases of Common Pathogenic Bacteria Degrade and Inactivate the Antibacterial Peptide LL-37.'
ACCESSION #
5721179

 

Related Articles

  • Foreword. Gottlieb, Alice // American Journal of Clinical Dermatology;Feb2014 Supplement, Vol. 15, p3 

    The article focuses on the clinical application of infliximab as tumor necrosis factor (TNF) inhibitor blocker. It discusses the studies "Treatment of Psoriasis: focus on clinic-based management with Infliximab," by E. de Eusebio, J. C. Armario-Hita, and D. V. A. de Miquel, and "Infliximab...

  • NEWS BRIEFS.  // Dermatology Times;Apr2008, Vol. 29 Issue 4, p30 

    The article reports developments related to dermatology in the U.S. The Food and Drug Administration's Drug Safety Newsletter is reporting serious skin reactions which can occur with tumor necrosis factor-alpha antagonists. A Food and Drug Administration advisory panel to review the use of...

  • Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-α therapy. Buommino, E.; Filippis, A.; Gaudiello, F.; Balato, A.; Balato, N.; Tufano, M.; Ayala, Fabio // Archives of Dermatological Research;Aug2012, Vol. 304 Issue 6, p481 

    Psoriasis is a chronic skin inflammatory disease in which a pleiotropic cytokine, tumor necrosis factor alpha (TNF-α), plays a central role, as demonstrated by the clinical success of anti-TNF-α therapy. Among the multiple effects of TNF-α on keratinocytes, the induction of matrix...

  • INVESTIGATIVE DERMATOLOGY.  // Current Medical Literature: Dermatology;2005, Vol. 10 Issue 1, p15 

    Presents several clinicians' notes on investigative dermatology. Changing patterns of sun protection between the first and second summers for very young children; Aggressive cutaneous T-cell lymphomas after TNF-alpha blockade; Future incidence of cutaneous melanoma in Great Britain; Reliability...

  • News from the 62nd annual meeting of the AAD.  // PharmacoEconomics & Outcomes News;3/27/2004, Issue 449, p6 

    Looks at the four presentations discussed during the 62nd annual meeting of the American Academy of Dermatology which was held in February 2004 in Washington, D.C. Information on the etanercept, a soluble tumour necrosis factor necrosis; Results of a study on the effect of tacrolimus ointment...

  • Pipeline offers promise for psoriasis therapies. Krader, Cheryl Guttman // Dermatology Times;Apr2014, Vol. 35 Issue 4, p1 

    The article explores the therapeutic options for psoriasis. Topics include IL-17 antibody like secukinumab and oral small molecules such as apremilast as the treatment for psoriatic arthritis, and the efficacy of topical azelaic acid and metronidazole for treating papulopustular rosacea (PPR)...

  • Increased ICAM-1 Expression Causes Endothelial Cell Leakiness, Cytoskeletal Reorganization and Junctional Alterations. Clark, Paul R.; Manes, Thomas D.; Pober, Jordan S.; Kluger, Martin S. // Journal of Investigative Dermatology;Apr2007, Vol. 127 Issue 4, p762 

    Tumor necrosis factor (TNF)-induced ICAM-1 in endothelial cells (EC) promotes leukocyte adhesion. Here we report that ICAM-1 also effects EC barrier function. Control- or E-selectin-transduced human dermal microvascular EC (HDMEC) form a barrier to flux of proteins and to passage of current...

  • NF-κB Inhibition Reveals Differential Mechanisms of TNF Versus TRAIL-Induced Apoptosis Upstream or at the Level of Caspase-8 Activation Independent of cIAP2. Diessenbacher, Philip; Hupe, Mike; Sprick, Martin R.; Kerstan, Andreas; Geserick, Peter; Haas, Tobias L.; Wachter, Tina; Neumann, Manfred; Walczak, Henning; Silke, John; Leverkus, Martin // Journal of Investigative Dermatology;May2008, Vol. 128 Issue 5, p1134 

    Death ligands not only activate a death program but also regulate inflammatory signalling pathways, for example, through NF-κB induction. Although tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF both activate NF-κB in human keratinocytes, only TRAIL potently...

  • Propionibacterium acnes Stimulates Pro-Matrix Metalloproteinase-2 Expression through Tumor Necrosis Factor-α in Human Dermal Fibroblasts. Jee-Young Choi; Mei Shan Piao; Jee-Bum Lee; Jong Seok Oh; In-Gyu Kim; Seung-Chul Lee // Journal of Investigative Dermatology;Apr2008, Vol. 128 Issue 4, p846 

    Propionibacterium acnes (P. acnes) is a commensal microorganism found in sebum-rich skin and plays a role in acne inflammation by stimulating keratinocyte to produce a number of proinflammatory cytokines. However, the role of P. acnes in the dermis of acne lesions, where tissue remodeling after...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics